Ethyl 2,3-dibromopropionate
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
3674-13-3CCOC(=O)C(Br)CBrOENICUBCLXKLJQ-UHFFFAOYSA-N3674-13-3DTXSID80871038Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301+H311 (37.7%): Toxic if swallowed or in contact with skin [Danger Acute toxicity, oral; acute toxicity, dermal]
P260, P262, P264, P264+P265, P270, P280, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P361+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 77 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 16-01-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/24693
Ethyl 2,3-dibromopropionate: Does not have an individual approval but may be used under an appropriate group standard
VerwendenEthyl 2,3-dibromopropionate is used as pharmaceutical Intermediates. It is a building block that has been used as a catalyst for the polymerization of ethyl acrylate.
Wird geladen…